471.03
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt VRTX?
Forum
Prognose
Aktiensplit
Finanzdaten der Vertex Pharmaceuticals Inc-Aktie (VRTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
3.69%
3,190.00
|
3,076.40 | 2,964.70 | 2,770.20 | 2,912.00 |
| Cost Of Revenue |
12.34%
466.00
|
414.80 | 407.50 | 363.00 | 423.40 |
| Gross Profit |
2.34%
2,724.00
|
2,661.60 | 2,557.20 | 2,407.20 | 2,488.60 |
|
|
2.89%
1,518.10
|
1,475.40 | 1,406.10 | 1,777.10 | 1,462.60 |
| Benefits Costs and Expenses |
4.58%
1,859.00
|
1,777.60 | 1,681.70 | 2,039.80 | 1,775.50 |
| Costs And Expenses |
4.97%
1,984.10
|
1,890.20 | 1,813.60 | 2,140.10 | 1,886.00 |
| Operating Income/Loss |
1.66%
1,205.90
|
1,186.20 | 1,151.10 | 630.10 | 1,026.00 |
| Income/Loss From Continuing Operations Before Tax |
2.48%
1,331.00
|
1,298.80 | 1,283.00 | 730.40 | 1,136.50 |
| Income Tax Expense/Benefit |
35.20%
139.90
|
215.90 | 250.10 | 84.10 | 223.50 |
| Income/Loss From Continuing Operations After Tax |
9.99%
1,191.10
|
1,082.90 | 1,032.90 | 646.30 | 913.00 |
|
|
9.99%
1,191.10
|
1,082.90 | 1,032.90 | 646.30 | 913.00 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
100.27%
-0.70
|
255.60 | 256.70 | 256.90 | -0.20 |
| Diluted Average Shares |
100.23%
-0.60
|
257.60 | 258.90 | 259.50 | -0.20 |
| Basic Earnings Per Share |
10.61%
4.69
|
4.24 | 4.02 | 2.52 | 3.53 |
| Diluted Earnings Per Share |
10.48%
4.64
|
4.20 | 3.99 | 2.49 | 3.53 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):